Back to top

Oncology

We are a national reference centre for the care and research of developmental cancer and an international reference centre.

The SJD Barcelona Children's Hospital's Oncology Department is a national reference centre for the care and research of developmental cancer and an international reference centre.

We are specialists in the treatment of all pediatric cancers: neuroblastoma, retinoblastoma, musculoskeletal tumours (sarcomas including osteosarcoma and Ewing's sarcoma), brain tumours (including medulloblastoma, ependymoma, gliomas and other less frequent ones), histiocytosis, renal tumours (Wilms' tumour and other less frequent ones), leukaemias (lymphoid and myeloid) and lymphomas. 

Accreditations:

Our departament has been officially recognised as a reference unit for the treatment of minority and complex diseases: 

  • European Commission (ERN): ERN PaedCan 
  • Ministry of Health, Consumer Affairs and Social Welfare (CSUR): Genetic neurocutaneous syndromes. 

We treat nearly 2,000 children and adolescents for all types of developmental cancer each year, 300 of whom are new patients at the Hospital.

We use the innovative therapy

We achieved the significant progress in the cancer´s treatment

Neuroblastoma

We perform a molecular evaluation of the tumour to determine if it requires aggressive post-surgery treatment. We are one of the centres in Europe to apply anti-GD2 immunotheraphy.

Retinoblastoma

We apply localised chemotherapy to the tumour by means of intra-arterial chemotherapy. We are the only centre which can offer intra vitreous therapy with virus in a clinical study.

Musculoskeletal tumours

We apply reconstruction techniques to the affected limb, with bone material from patients themselves or from a donor, to avoid amputation.

At the forefront of knowledge

The SJD Barcelona Children's Hospital is able to offer all techniques for molecular diagnosis and disease prognosis to our patients, while working to develop new, more effective and less aggressive therapies for children suffering from cancer.

Read more about research

Our outcomes

Retinoblastoma in advanced stages
90
%
Eye preservation rate
Focal cerebral tumour
90
%
Survival rate
Localised Ewing's sarcoma
84
%
Cure rate
Localised osteosarcomas
85
%
Cure rate
Douglas tripped over things before, I had to guide him, not anymore. He goes to the park, plays and there is no need to give him a hand
Katherine, mother of Douglas, patient with retinoblastoma
Immunotherapy has allowed us to see how our child continues to grow
The mother of Ivan

Pediatric Cancer Center Barcelona

A comprehensive centre for the benefit of children and adolescents with cancer.

LEARN MORE

How to get your child admitted to SJD Barcelona Children’s Hospital

Share